Search Results

• • 15 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design.

  Authors:Aziz Sheikh, Steven Kerr, Mark Woolhouse, Jim McMenamin, Chris Robertson, Colin Richard Simpson, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022431 words Report

   Abstract Only

• Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study.

  Authors:Bing Wang, Lynne Giles, Prabha Andraweera, Mark McMillan, Sara Almond, Rebecca Beazley, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022692 words Article

   Abstract Only

• Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study.

  Authors:Norbert Ndjeka, Jonathon R Campbell, Graeme Meintjes, Gary Maartens, H Simon Schaaf, Jennifer Hughes, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022736 words Report

   Abstract Only

• Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study.

  Authors:Winston E Abara, Kyle T Bernstein, Felicia M T Lewis, Julia A Schillinger, Kristen Feemster, Preeti Pathela, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022490 words Article

   Abstract Only

• Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.

  Authors:Igor Smolenov, Htay Htay Han, Ping Li, Carmen Baccarini, Carole Verhoeven, Frank Rockhold, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022655 words Report

   Abstract Only

• Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India.

  Authors:Inderpaul S Sehgal, Sahajal Dhooria, Valliappan Muthu, Kuruswamy T Prasad, Ashutosh N Aggarwal, Arunaloke Chakrabarti, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022530 words Report

   Abstract Only

• Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1--2 randomised controlled trial.

  Authors:Nicolas Folschweiller, Carline Vanden Abeele, Laurence Chu, Pierre Van Damme, Adolfo García-Sastre, Florian Krammer, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022754 words Article

   Abstract Only

• Spleen nodules in Loa loa infection: re-emerging knowledge and future perspectives.

  Authors:Francesca Tamarozzi, Dora Buonfrate, Davide Ricaboni, Tamara Ursini, Giovanni Foti, and Federico GobbiFrom:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022212 words Brief article

   Abstract Only

• Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.

  Authors:Peter Bager, Jan Wohlfahrt, Samir Bhatt, Marc Stegger, Rebecca Legarth, Camilla Holten Møller, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022740 words Article

   Abstract Only

• Invasive group A streptococcal disease in pregnant women and young children: a systematic review and meta-analysis.

  Authors:Emma Sherwood, Stefania Vergnano, Isona Kakuchi, Michael G Bruce, Suman Chaurasia, Samara David, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022853 words Article

   Abstract Only

• Screening and vaccination against COVID-19 to minimise school closure: a modelling study.

  Authors:Elisabetta Colosi, Giulia Bassignana, Diego Andrés Contreras, Canelle Poirier, Pierre-Yves Boëlle, Simon Cauchemez, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022595 words Article

   Abstract Only

• COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.

  Authors:Cristina Menni, Anna May, Lorenzo Polidori, Panayiotis Louca, Jonathan Wolf, Joan Capdevila, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022579 words Clinical report

   Abstract Only

• Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases.

  Authors:Christoph Lange, Erik C Böttger, Emmanuelle Cambau, David E Griffith, Lorenzo Guglielmetti, Jakko van Ingen, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022583 words Article

   Abstract Only

• 25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward.

  Authors:Anna S Dean, Olga Tosas Auguet, Philippe Glaziou, Matteo Zignol, Nazir Ismail, Tereza Kasaeva, et al.From:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022308 words Brief article

   Abstract Only

• Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis.

  Authors:Lilith K Whittles, Xavier Didelot, and Peter J WhiteFrom:The Lancet Infectious Diseases (Vol. 22, Issue 7) Peer-Reviewed

  July 2022723 words Article

   Abstract Only